Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis

被引:28
作者
Keadle, TL
Stuart, PM
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Microbiol & Mol Pathogenesis, St Louis, MO 63110 USA
关键词
interleukin-10 (IL-10); herpetic stromal keratitis; Delayed Type Hypersensitivity (DTH);
D O I
10.1016/j.micpath.2004.09.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 10 (IL-10), a moderator of Delayed Type Hypersensitivity (DTH) responses, has been demonstrated to be present late in acute HSV corneal infection and may help limit blinding inflammatory lesions there. In contrast, IL-10 is present early in the development of recurrent herpetic stromal keratitis (HSK) lesions in mice. To determine the role of IL-10 and DTH responses in recurrent HSK, we examined DTH responses and disease parameters in latently infected IL-10 knock out (KO) mice, and latently infected normal mice that were untreated cr received anti-IL-10 antibodies or recombinant IL-10 following ultraviolet-B stimulated ocular HSV recurrence. Low DTH responses were associated with less severe corneal disease while high DTH responses were associated with greater corneal disease. In IL-10 KO mice, and in normal mice given anti-IL-10 antibodies, corneal opacification was increased and DTH responses were significantly prolonged. Normal mice receiving rIL-10 by ocular and intra-peritoneal routes had less severe corneal lesions. Our results indicate that IL-10 and DTH responses play an important role in the pathogenesis of recurrent HSK in mice. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 38 条
[1]   Interleukin-10 therapy - Review of a new approach [J].
Asadullah, K ;
Sterry, W ;
Volk, HD .
PHARMACOLOGICAL REVIEWS, 2003, 55 (02) :241-269
[2]  
BABU JS, 1995, J IMMUNOL, V154, P4822
[3]  
CHACE JH, 1994, J IMMUNOL, V152, P405
[4]   Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes [J].
Chun, SJ ;
Daheshia, M ;
Kuklin, NA ;
Rouse, BT .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5545-5551
[5]   Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice [J].
Cole, N ;
Krockenberger, M ;
Stapleton, F ;
Khan, S ;
Hume, E ;
Husband, AJ ;
Wilicox, M .
INFECTION AND IMMUNITY, 2003, 71 (03) :1328-1336
[6]   Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines [J].
Daheshia, M ;
Kuklin, N ;
Manickan, E ;
Chun, S ;
Rouse, BT .
VACCINE, 1998, 16 (11-12) :1103-1110
[7]  
Daheshia M, 1997, J IMMUNOL, V159, P1945
[8]  
DOYMAZ MZ, 1992, INVEST OPHTH VIS SCI, V33, P2165
[9]   GENETIC-STUDIES ON MURINE SUSCEPTIBILITY TO HERPES-SIMPLEX KERATITIS [J].
FOSTER, CS ;
TSAI, Y ;
MONROE, JG ;
CAMPBELL, R ;
CESTARI, M ;
WETZIG, R ;
KNIPE, D ;
GREENE, MI .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 40 (02) :313-325
[10]   Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation [J].
Garcia-Hernández, ML ;
Hernández-Pando, R ;
Gariglio, P ;
Berumen, J .
IMMUNOLOGY, 2002, 105 (02) :231-243